No Data
No Data
Mailande (688273.SH): First repurchase of 20,000 shares of company stock.
On July 3rd, Gelonhui reported that Mailand (688273.SH) repurchased 20,000 shares of the company through the Shanghai Stock Exchange trading system through centralized bidding trading for the first time on July 3rd, 2024. The repurchased shares accounted for 0.02% of the company's total share capital of 100,000,000 shares. The highest and lowest repurchase prices were 19.44 yuan/share and 19.35 yuan/share respectively. The total amount paid was RMB 387,961.19 (excluding stamp duty, transaction fees, and commissions).
Maiden (688273.SH): Annual equity distribution in 2023 is 10 shares, 6 yuan per share.
On June 18th, Gelonghui reported that Mailande (688273.SH) announced an annual equity dividend of 0.6 yuan per share of cash (tax included) for 2023, and the cash dividend payment date is June 25th, 2024.
Mailande (688273.SH) plans to distribute 0.6 yuan per share and pay dividends on June 25th.
McLane (stock code 688273.SH) announced that it plans to distribute equity dividends for the fiscal year 2023: a cash dividend of 0 yuan per share...
Meilande (688273.SH): Some hospitals have completed sales of the company's new products.
On June 4th, Gelunhui reported that Mailande (688273.SH) announced the performance and cash dividend for the company in 2023 and the first quarter of 2024 at a meeting. The company launched the self-developed "Magnetic-Electric-Thermal Imaging - Intelligent Integration PI-ONE" pelvic floor intelligent diagnosis and treatment system in early March this year, with industry-leading technology. The product integrates the structure and functional information of the pelvic floor, comprehensively evaluates the pelvic floor status, and assists doctors in matching personalized magnetic, electric, and thermal treatment plans for patients through big data and intelligent algorithms. This solves the long-term problems of "difficult diagnosis", "multiple treatment options, difficult to choose treatment methods and plans", and "research and development".
Mayland (688273.SH): 1.11 million shares of the company have actually been repurchased
On June 2, GLONGHUI (688273.SH) announced that as of May 31, 2024, the company had completed the repurchase and had actually repurchased 1.11 million shares of the company's shares, accounting for 1.11% of the company's total share capital. The highest price of the repurchase transaction was 34.44 yuan/share, the lowest price was 19.32 yuan/share, the average price was 29.01 yuan/share, and the total amount of capital paid was RMB 32.2051 million (excluding transaction fees such as stamp duty and transaction fees).
Medlander Medical Technology Scraps 193 Million Yuan Maidou Health Deal
Nanjing Medlander Medical Technology (SHA:688273) terminated plans to acquire 55% of Nanjing Maidou Health Technology for 192.5 million yuan, according to a Friday filing with the Shanghai Stock Excha
No Data